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AscInﬂammasome, an intracellular inﬂammatorymachinery, has been reported to be involved in a variety of chronic
degenerative diseases such as atherosclerosis, autoinﬂammatory diseases and Alzheimer's disease. The present
study hypothesized that the formation and activation of inﬂammasomes associated with apoptosis associated
speck-like protein (ASC) are an important initiating mechanism resulting in obesity-associated podocyte injury
and consequent glomerular sclerosis. To test this hypothesis, Asc gene knockout (Asc−/−), wild type (Asc+/+)
and intrarenal Asc shRNA-transfected wild type (Asc shRNA) mice were fed a high fat diet (HFD) or normal
diet (ND) for 12 weeks to produce obesity and associated glomerular injury. Western blot and RT-PCR analyses
demonstrated that renal tissue Asc expression was lacking in Asc−/−mice or substantially reduced in Asc shRNA
transfected mice compared to Asc+/+ mice. Confocal microscopic and co-immunoprecipitation analysis showed
that the HFD enhanced the formation of inﬂammasome associated with Asc in podocytes as shown by
colocalization of Asc with Nod-like receptor protein 3 (Nalp3). This inﬂammasome complex aggregation was
not observed in Asc−/− and local Asc shRNA-transfected mice. The caspase-1 activity, IL-1β production and
glomerular damage index (GDI) were also signiﬁcantly attenuated in Asc−/− and Asc shRNA-transfected mice
fed the HFD. This decreased GDI in Asc−/− and Asc shRNA transfected mice on the HFD was accompanied by
attenuated proteinuria, albuminuria, foot process effacement of podocytes and loss of podocyte slit diaphragm
molecules. In conclusion, activation and formation of inﬂammasomes in podocytes are importantly implicated
in the development of obesity-associated glomerular injury.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Obesity has greatly increased in Western countries over the last
three decades [1–5]. The prevalence of obesity (body mass index BMI
30 kg/m2) is 66% in the United States and between 7 and 37% in
Europe [1–5]. Obesity is associatedwith and contributes to the develop-
ment of type 2 diabetes mellitus, cardiovascular diseases, and non-
diabetic chronic kidney disease (CKD) [6]. CKD is now considered as
one of the strongest risk factors for the morbidity and mortality in
obese patients [7,8]. Experimental and clinical studies reveal that adi-
pose tissue, especially visceral fat generates bioactive substances that
contribute to the pathophysiologic renal hemodynamic and structural
changes leading to obesity-associated glomerular injury [9]. So far a
few mechanisms have been proposed for the obesity-induced CKDcology and Toxicology, Virginia
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ights reserved.including chronic inﬂammation, abnormal vascular remodeling, rise in
renal plasma ﬂow, hyperﬁltration and renal lipotoxicity [10]. However,
the underlyingmolecularmechanisms involved in obesity-induced glo-
merular injury, speciﬁcally, the early initiating processes responsible for
the glomerular injury during obesity, remain poorly understood.
In this regard, the inﬂammasome is a newly identiﬁed cellular ma-
chinery responsible for the activation of innate inﬂammatory processes
[11] and instigation of inﬂammatory responses during a variety of
chronic degenerative diseases such as atherosclerosis [12,13] and
Alzheimer's disease [14,15] as well as various auto inﬂammatory dis-
eases including obesity, diabetes, gout, silicosis, and acetaminophen-
induced liver toxicity [16–22]. Amongdifferent kinds of inﬂammasomes,
the NALP3 inﬂammasome is the most fully characterized in a variety of
mammalian cells. NALP3 inﬂammasome is a proteolytic complex com-
posed of the Nod-like receptor protein 3 (NALP3), the adaptor protein
apoptosis associated speck-like protein (Asc), and caspase-1 [22],
which is vital for the production of mature IL-1β in response to a variety
of agonists or stimuli. It has been reported that IL-1β is an important
cytokine with a broad range of biological activities [19,23] involved in
kidney injury and repair [24–26] and that in glomeruli it is mainly pro-
duced by podocytes [27,28]. The active mature interleukin-1β (IL-1β)
837K.M. Boini et al. / Biochimica et Biophysica Acta 1843 (2014) 836–845is formed by cleaving inactive pro IL-1βprecursor via caspase-1,which is
activated in a large multiprotein complex, namely, the inﬂammasome
[23,29–35]. The Nalp3 inﬂammasome has been reported to be activated
by several stimulants such as ATP, monosodium urate crystals (MSU)
[20] or β-amyloid [36]. It has been shown that in the kidney NALP3
inﬂammasomes are one of the triggering mechanisms responsible for
hyperhomocysteinemia-induced glomerular injury, furthermore it par-
ticipates in acute ischemia/reperfusion-induced kidney injury, unilateral
ureteral obstruction-induced renal damage and non-diabetic human
kidney disease [25,26,37–40]. However, it remains unknown whether
obesity activates the NALP3 inﬂammasomes and thereby results in glo-
merular injury in the kidney.
The present study hypothesized that the formation and activation of
NALP3 inﬂammasomes are an important initiatingmechanism resulting
in obesity-associated glomerular injury. To test our hypothesis, we used
Asc−/− and local Asc gene silencing strategies to examine the role of
inﬂammasomes-associated with Asc in obesity-induced glomerular
injury. Because ASC is a key inﬂammasome adaptor for NALP3
inﬂammasomes [20,41], gene knockout or locally silencing the Asc
gene may mainly block the formation and activation of NALP3
inﬂammasomes in podocytes. Our results demonstrate that the forma-
tion and activation of NALP3 inﬂammasomes in podocytes may be im-
portantly implicated in the development of glomerular injury and
ultimate sclerosis during obesity.
2. Materials and methods
2.1. Animals
Eight weeks old male Asc−/− mice and their wild type littermates
were used in the present study [11,41]. The mice were fed either a
low fat diet (LFD: D 12450B, 10 kcal % fat, Research Diets, New Bruns-
wick, NJ) or a high fat diet (HFD: D 12492, 60 kcal % fat, Research
Diets, New Brunswick, NJ) for 12 weeks [42–44]. In another series,
eight week old male C57BL/6J or DBA/2J wild type mice (Jackson Labo-
ratories, Bar Harbor, ME), Asc shRNA or a scrambled shRNA (Origene,
Rockville, MD, USA) plasmid with a luciferase expression vector was
co-transfected into the kidneys via intrarenal artery injection using
the ultrasound microbubble system as we described previously [45].
After the delivery of plasmids into the kidney, mice were fed either a
normal diet or HFD for 12 weeks. All protocols were approved by the
Institutional Animal Care and Use Committee of the Virginia Common-
wealth University.
2.2. Caspase-1 activity, IL-1β production, plasma insulin, triglycerides and
total cholesterol
Caspase-1 activity in glomeruli was measured by a commercially
available colorimetric assay kit (Biovision, Mountain View, CA). IL-1β
production in glomeruli was measured by a commercially available
ELISA kit (R&D System, Minneapolis, MN), according to the
manufacturer's instructions [26,46]. Plasma concentrations of insulin
were determined using an ELISA kit (Crystal Chem, USA). Total choles-
terol (Cayman Chemical Company, USA) and triglycerides (Sigma)
were analyzed using a colorimetric assay.
2.3. Morphological examinations
The ﬁxed kidneys were parafﬁn-embedded, and sections were pre-
pared and stained with Periodic acid–Schiff stain. Glomerular damage
index (GDI) was calculated from 0 to 4 on the basis of the degree of
glomerulosclerosis and mesangial matrix expansion as described previ-
ously [47,48]. In general, we counted 50 glomeruli in total in each
kidney slice under microscope, when each glomerulus was graded
level 0–4 damages. 0 represents no lesion, 1+ represents sclerosis of
b25% of the glomerulus, while 2+, 3+, and 4+ represent sclerosis of25% to 50%, N50% to 75%, and N75% of the glomerulus. A whole kidney
average sclerosis index was obtained by averaging scores from counted
glomeruli. This observation was examined by two independent investi-
gators who were blinded to the treatment of the experimental groups
[26,45–48].
2.4. Urinary total protein and albumin excretion measurements
The24-hour urine sampleswere collected usingmetabolic cages and
subjected to total protein and albumin excretion measurements, re-
spectively [45,47,48]. Total protein content in the urine was detected
by Bradford method using a UV spectrophotometer. Urine albumin
was detected using a commercially available albumin ELISA kit (Bethyl
Laboratories, Montgomery, TX).
2.5. Delivery of Asc shRNA into the kidneys by ultrasound-microbubble
technique
Asc shRNA or a scrambled shRNA plasmid with a luciferase expres-
sion vector was used to co-transfect the kidneys via intrarenal artery
injection using the ultrasound-microbubble system. These experiments
were performed to test whether local silencing Asc gene expression in
podocytes alters obesity-induced glomerular injury. A full description
of the procedures for the ultrasound-microbubble gene transfer tech-
nique can be found in our previous studies [26,45,47]. To monitor the
efﬁciency of gene expression through somatic plasmid transfection
daily, mice were anesthetized with isoﬂurane, and an aqueous solution
of luciferin (150 mg/kg)was injected intraperitoneally 5min before im-
aging. The anesthetized mice were imaged using the IVIS200 in vivo
molecular imaging system (Xenogen, Hopkinton, MA, USA). Photons
emitted from luciferase-expressing cells within the animal body and
transmitted through tissue layers were quantiﬁed over a deﬁned period
of time ranging up to 5min using the software program Living Image as
program (Xenogen). The inhibitory efﬁciency of gene expression by Asc
shRNA was further conﬁrmed by the detection of Asc level in mouse
renal cortex using real-time RT-PCR.
2.6. Real-time reverse transcription polymerase chain reaction (RT-PCR)
Total RNA from isolated mouse renal tissue was extracted using
TRIzol reagent (Invitrogen, Carlsbad, CA) according to the protocol as
described by the manufacturer. RNA samples were quantiﬁed by mea-
surement of optic absorbance at 260 nm and 280 nm in a spectropho-
tometer. The concentrations of RNA were calculated according to
A260. Aliquots of total RNA (1 μg) from each sample were reverse-
transcribed into cDNA according to the instructions of the ﬁrst strand
cDNA synthesis kit manufacturer (Bio-Rad, Hercules, CA). Equal
amounts of the reverse transcriptional products were subjected to PCR
ampliﬁcation using SYBR Green as the ﬂuorescence indicator on a Bio-
Rad iCycler system (Bio-Rad, Hercules, CA) [26,45,47]. The primers
used in this study were synthesized by Operon (Huntsville, AL, USA)
and the sequenceswere: for Asc sense ACAGAAGTGGACGGAGTGCT, an-
tisense CTCCAGGTCCATCACCAAGT; for Podocin sense GTGGAAGCTGAG
GCACAAAGAC, antisense CAGCGACTGAAGA GTGTGCAAG; for desmin
sense CAGTCCTACACCTGCGAGATT, antisense GGCCA TCTTCACATTGA
GC; for MCP-1 sense ACCACAGTCCATGCCATCAC, antisense TTGAGGTG
GTTGTGGAAAAG; for IL-18 sense GCTTGAATCTAAATTATCAGTC, anti-
sense GAAGATTCAAATTGCATCTTAT and for β-actin sense TCGCTGCG
CTGGTCGTC, antisense GGCCTCGTCACCCACATAGGA.
2.7. Confocal microscopic detection of inﬂammasome protein complexes
Indirect immunoﬂuorescent staining was used to determine colo-
calization of the inﬂammasome proteins in glomeruli of themouse kid-
ney,which indicate the formationof inﬂammasomemolecular complex.
Frozen kidney tissue slides were ﬁxed in acetone and then incubated
Fig. 1. Genotyping and Asc expression in Asc+/+ and Asc−/− mice. A. Genotyping in
Asc+/+ and Asc−/− mice. Detection of PCR product at 450 bp represents Asc+/+ mice,
while a PCR product of 260 bp represents Asc−/− mice. B. Western blot analysis of Asc
protein expression in mice. C. Values are arithmetic means ± SD (n = 4 each group) of
Asc mRNA expression in Asc+/+ and Asc−/− mice. *Signiﬁcant difference (P b 0.05)
+/+
Table 1
Blood glucose, plasma insulin, triglycerides, total cholesterol concentrations in Asc+/+ and
Asc−/−mice fed a ND or high fat diet treatment.
Parameters Asc+/+ ND Asc−/− ND Asc+/+ HFD Asc−/− HFD
Blood glucose (mg/dl) 121 ± 2.0 111 ± 10.3 156 ± 9.0⁎ 110.9 ± 23.0#
Plasma insulin (ng/ml) 0.9 ± 0.1 0.8 ± 0.2 3.6 ± 0.4⁎ 1.5 ± 0.4#
Triglycerides (mg/dl) 64 ± 4.6 59 ± 7.0 113 ± 13⁎ 83 ± 7
Total cholesterol (mg/dl) 149 ± 4.3 145 ± 8.0 178 ± 8⁎ 162 ± 8
ND: Normal diet, HFD: high fat diet. N = 5–6 in each group. The data was expressed as
mean ± SEM.
⁎ P b 0.05 as comparedwith Asc+/+ND. # Signiﬁcant difference (Pb 0.05) compared to
the values from Asc+/+ mice receiving the HFD.
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Asc (1:50), or goat anti-Nalp3 (1:200) and mouse anti-caspase-1
(1:100). To further conﬁrm the presence of the inﬂammasomes specif-
ically in podocytes of the mouse glomeruli, Nalp3 or caspase-1 was co-
incubated with a podocin antibody (1:400; Sigma, St. Louis, MO). Dou-
ble immunoﬂuorescent stainingwas achieved by incubatingwith either
Alexa-488 or Alexa-555-labeled secondary antibodies for 1 h at room
temperature. After washing, slides were mounted with a DAPI-
containing mounting solution, and then observed with a confocal laser
scanningmicroscope (Fluoview FV1000, Olympus, Japan). As previously
described [26,47], images were analyzed by the Image Pro Plus 6.0 soft-
ware (Media Cybernetics, Bethesda, MD), where colocalization was
measured and expressed as the Pearson Correlation Coefﬁcient (PCC).
2.8. Transmission electron microscopy (TEM)
For TEM observation of ultrastructural changes in podocytes, the
mouse kidneys were perfused with a ﬁxative containing 3% glutaralde-
hyde and 4% paraformaldehyde in 0.1Mphosphate buffer. After ﬁxation
and dehydration with ethanol, the samples were embedded in
Durcupan resin for ultra-thin sectioning and TEM examination by the
VCU electron microscopy core facility [26,49].
2.9. Immunohistochemistry
Kidneys were embedded with parafﬁn and 5 mm sections were cut
from the embedded blocks. After heat-induced antigen retrieval, CD43
staining of T cells [46,50] required citrate buffer antigen retrieval.
After a 20 min wash with 3% H2O2 and 30 min blocking with serum,
slides were incubated with primary antibodies diluted in phosphate-
buffered saline (PBS) with 4% serum. Anti-CD43 (1:50; Santa Cruz
Biotechnology, Santa Cruz, CA) antibody was used in this study. After
incubation with primary antibody overnight, the sections were washed
in PBS and incubated with biotinylated IgG (1:200) for 1 h and then
with streptavidin-HRP for 30 min at room temperature. 50 μl of DAB
was added to each kidney section and stained for 1 min. After washing,
the slides were counterstained with hematoxylin for 5 min. The slides
were then mounted and observed under a microscope in which photos
were taken.
2.10. Statistical analysis
Data are provided as arithmetic means ± SEM; n represents the
number of independent experiments. All data were tested for signiﬁ-
cance using ANOVA or paired and unpaired Student's t-tests as applica-
ble. The glomerular damage index was analyzed using a nonparametric
Mann–Whitney rank sum test. Only results with P b 0.05 were consid-
ered statistically signiﬁcant.
3. Results
3.1. Characterization of Asc gene knockout mice
As shown in Fig. 1A, Asc knockout (Asc−/−) and wild type (Asc+/+)
were genotyped using PCR. Detection of a PCR product at 260 indicates
Asc−/−, while a PCR product of 450 bp indicates Asc+/+ mice. Western
blot analysis revealed that Asc protein was hardly detected in the glo-
meruli of Asc−/− mice, but it was enriched in the glomeruli of Asc+/+
mice (Fig. 1B). Furthermore, real time RT-PCR analysis also showed
that Asc mRNA expression was not detectable in the glomeruli of
Asc−/− mice (Fig. 1C), conﬁrming the Asc gene deletion in mice. The
body weight was similar in Asc+/+ and Asc−/−mice fed a normal diet.
The high fat diet (HFD) signiﬁcantly increased the body weight in
Asc+/+ mice compared to normal diet-fed mice. However, Asc−/−
mice attenuated HFD-induced increase in body weight (Asc+/+ mice:
44.6 ± 2.0 vs. 26.2 ± 1.41 g of control and Asc−/−mice: 33.4 ± 8.6 vs.26.0±0.8 g of control atweek 10). HFD signiﬁcantly increased the plas-
ma glucose, insulin, total cholesterol and triglyceride levels in Asc+/+
compared to controlmice.However,Asc−/−mice signiﬁcantly attenuated
the HFD-induced blood glucose, plasma insulin concentrations but did
not alter the plasma total cholesterol and triglyceride levels (Table 1).
These data demonstrate that obesity was induced in HFD-fed mice.
compared to the values from Asc mice.3.2. Formation and activation of podocyte Nalp3 inﬂammasomes in obesity
As shown in Fig. 2A, confocal microscopic analysis demonstrated
that HFD increased the colocalization of Nalp3 with Asc (yellow spots)
or Nalp3 with caspase-1 (yellow spots) in glomeruli of Asc+/+ mice
compared to normal diet (ND)-fed mice. Furthermore, colocalization
of Nalp3 with podocin (podocyte marker) indicates enrichment of
Nalp3 in podocytes (yellow spots). However, in Asc−/− mice such
Fig. 2. Formation of podocyte Nalp3 inﬂammasomes in glomeruli of Asc+/+ and Asc−/−
mice fed with ND or high fat diet. A. Overlaid images (yellow spots) show the
colocalization of Nalp3 (green) with Asc (red), Nalp3 (green) with caspase-1 (red) and
Nalp3 (green) with podocin (red) in mouse glomeruli. B. Summarized data shows the
fold changes of Pearson coefﬁcient correlation (PCC) for the colocalization of Nalp3 with
Asc and Nalp3 with caspase-1 in glomeruli of Asc+/+ and Asc−/− mice fed with either
ND or HFD. C. Immunoprecipitation and Western blot analysis of the interaction of
Nalp3 with ASC in glomeruli of either ND or HFD fed mice. Casp-1: Caspase-1 and Podo:
Podocin. *Signiﬁcant difference (P b 0.05) compared to the values fromND fedmice, #sig-
niﬁcant difference (P b 0.05) compared to the values from Asc+/+mice receiving the HFD. Fig. 3. Activation of podocyte Nalp3 inﬂammasomes in glomeruli of Asc
+/+ and Asc−/−
mice fed with ND or high fat diet. Values are arithmetic means ± SD (n = 6 each
group) of caspase-1 activity (A), cleaved IL-1β concentration (B), IL-1B production (C) in
glomeruli of Asc+/+ and Asc−/− mice fed with either ND or HFD. *Signiﬁcant difference
(P b 0.05) compared to the values from ND fed mice, #signiﬁcant difference (P b 0.05)
compared to the values from Asc+/+ mice receiving the HFD.
Table 2
MCP-1 and IL-18 expression in glomeruli of Asc+/+ and Asc−/−mice fed a ND or high fat
diet treatment.
Parameters Asc+/+ ND Asc−/− ND Asc+/+ HFD Asc−/− HFD
839K.M. Boini et al. / Biochimica et Biophysica Acta 1843 (2014) 836–845colocalizations were not detected (Fig. 2A). These results suggest the
formation of Nalp3 inﬂammasomes in glomeruli of obese mice. The
summarized data of quantitative colocalization of Nalp3 with Asc or
caspase-1 in glomeruli of mice were shown in Fig. 2B. In addition,
coimmunoprecipitation (Co-IP) experiments also demonstrated that
the HFD signiﬁcantly increased the binding of Asc together with Nalp3
in glomeruli of Asc+/+ mice compared to ND, which was again attenu-
ated in Asc−/−mice fed a HFD (Fig. 2C). These results further conﬁrm
the formation of Nalp3 inﬂammasomes in glomeruli of obese mice,
which is associated with a normal expression of Asc gene. Biochemical
analysis showed that the HFD signiﬁcantly increased caspase-1 activity
and IL-1β production in glomeruli of Asc+/+ mice but not in Asc−/−
mice (Fig. 3). In addition, Asc−/− mice signiﬁcantly attenuated the
HFD-induced MCP-1 and IL-18 expression compared to Asc+/+ mice
(Table 2), suggesting an abolishment of activation of podocyte Nalp3
inﬂammasomes during obesity by deletion of mouse Asc gene.MCP-1 1.0 ± 0.1 0.8 ± 0.1 3.5 ± 0.4⁎ 0.9 ± 0.1#
IL-18 1.0 ± 0.1 0.8 ± 0.1 1.6 ± 0.4⁎ 1.1 ± 0.1#
Quantitative real time PCR analysis was performed and the values were normalized
against β-actin. The data was expressed as mean ± SEM. ND: Normal diet, HFD: high
fat diet. n = 4 in each group. ⁎ Signiﬁcant difference (P b 0.05) compared to the values
from control mice on the normal diet, # Signiﬁcant difference (P b 0.05) compared to
versus values from mice fed the HFD.3.3. Contribution of Nalp3 inﬂammasomes to obesity-induced glomerular
inﬂammation and injury
We also detected the inﬂammatory response in glomeruli using Im-
munohistochemical assay with antibodies against surface antigen ofmouse T-cell (anti-CD43). Itwas found that theHFD-induced T-cell inﬁl-
tration (CD43+ staining) or aggregation within the glomeruli of obese
Asc+/+ mice. However, the HFD fed Asc−/− glomeruli had relatively
less T-cell inﬁltration compared to the HFD-fed Asc+/+ mice (Fig. 4A).
These results support the view that obesity leads to glomerular
840 K.M. Boini et al. / Biochimica et Biophysica Acta 1843 (2014) 836–845inﬂammation through Nalp3 inﬂammasome activation inmice. Further
functional studies showed that urinary albumin excretion was signiﬁ-
cantly higher in HFD-fed mice compared to ND-fed mice. The Asc−/−
mice had signiﬁcantly decreased urinary albumin excretion compared
to Asc+/+ mice (Fig. 4B). Furthermore, HFD-fed Asc+/+ mice produced
signiﬁcantmorphological changes in the glomeruli includingmesangial
expansion, capillary collapse and increased cellularity (Fig. 4C), which
was signiﬁcantly attenuated in the Asc−/− mice. The glomerular
damage index (GDI) was signiﬁcantly higher in Asc+/+ mice fed a
HFD compared to the ND. However, the HFD-induced increase in GDI
was signiﬁcantly attenuated in Asc−/− mice (Fig. 4D). These results
strongly suggest that the formation and activation of inﬂammasome
associated with ASC are an important early mechanism responsible
for glomerular inﬂammation and injury in obese mice.
Further experimentswere performed to test whether inﬂammasome-
mediated glomerular injury is due to podocyte dysfunction or injury.
Real time RT-PCR analysis showed that podocin expression (podocyte
injury marker) was found markedly reduced in glomeruli of HFD-fed
Asc+/+ mice than in ND-fed mice, indicating podocyte injury. The
Asc−/− mice showed signiﬁcantly less HFD-induced reduction of
podocin expression (Fig. 5A). In contrast, another podocyte injury
marker, desmin was found markedly increased in glomeruli of Asc+/+
mice on the HFD compared to those on the normal diet. However, this
increased desmin expression did not occur in Asc−/− mice even on
the HFD (Fig. 5B and C). Under transmission electron microscopy
(TEM), the intact structure of podocyte foot processes shown in glomer-
uli of mice were observed in ND-fed mice, while it was destroyed in
HFD-fed mice, as shown by evident foot process effacement in HFD-
fed Asc+/+mice. In contrast, podocytes of HFD fed Asc−/− had relatively
normal ultrastructures (Fig. 5D), indicating attenuated podocyte injury
within the glomeruli of obese mice.Fig. 4. Effects of the normal diet and HFD on glomerular injury in Asc+/+ and Asc−/−mice. A
glomeruli of Asc+/+ on high fat diet. B: Values are arithmetic means ± SD (n= 6 each group)
tomicrographs show typical glomerular structure (original magniﬁcation, ×400) in Asc+/+ and
(GDI) by semi-quantitation of scores in 4 different groups of mice (n= 6 each group). For each
difference (P b 0.05) compared to the values from ND fed mice, #signiﬁcant difference (P b 0.03.4. Local silencing of Asc gene attenuated the inﬂammasome formation in
glomeruli of obese mice
To further determine whether local inhibition of Asc gene expres-
sion alters the obesity-induced Nalp3 inﬂammasome activation and for-
mation in podocytes of mice, shRNA strategy was used to silence this
gene in the kidney and then observe the changes in body weight, glo-
merular function and pathology in obese mice. As illustrated in Fig. 6,
using IVIS in vivomolecular imaging system, luciferase gene expression
co-transfectedwithAsc shRNA could be detected even on the fourth day
after the kidneywas transfected byultrasound-microbubble plasmid in-
troduction. In the hemi-dissected kidney, all of the cortical regionswere
observed to exhibit efﬁcient gene transfection as shown in green and
red ﬂuorescence (Fig. 6A and B). This result is consistent with previous
studies showing that ultrasound-microbubble gene introduction is an
efﬁcient technique for delivery of the gene into the glomerular cells,
vascular endothelial cells, and ﬁbroblasts [42]. Such in vivo monitoring
of gene expression was used to guide functional studies. The efﬁciency
of local Asc gene silencing was also examined by measurement of
mRNA expression when animals were sacriﬁced after the completion
of functional studies. Real time PCR analysis demonstrated that Asc
mRNA expression was signiﬁcantly decreased in C57BL/6J WT mice
transfected with Asc shRNA compared to control mice (scramble
shRNA). The HFD signiﬁcantly increased the Asc mRNA expression in
glomeruli from mice receiving scrambled shRNA compared to ND-fed
mice, but it had no effect on Asc mRNA abundance in mice receiving
Asc shRNA (Fig. 6C). Asc shRNA transfection did not alter the Asc
mRNA expression in liver, heart and adipose tissues compared to con-
trol (scramble shRNA) mice (Table 3). Furthermore, the Asc shRNA
transfection did not alter the body weight in ND and HFD fed mice
(scramble shRNA: 40.8 ± 2.5 vs. 26.0 ± 1.2 g of control and Asc: Asc−/− mice prevented the increased expression and staining of T-cell marker CD43 in
of urinary albumin excretion in Asc+/+ and Asc−/−mice with or without the HFD. C: Pho-
Asc−/−mice fed with or without HFD. D: Summarized data of glomerular damage index
kidney section, 50 glomeruli were randomly chosen for the calculation of GDI. *Signiﬁcant
5) compared to the values from Asc+/+ mice receiving the HFD.
Fig. 5. Immunoﬂuorescence staining and expression of desmin and podocin in glomeruli from Asc−/− and Asc+/+mice fed a ND or HFD. A. Real-time RT-PCR analysis showing changes in
the expression of podocin in the glomeruli from different groups of mice (n= 6 per group). B. Real-time RT-PCR analysis showing changes in the expression of desmin in the glomeruli
from different groups of mice (n= 6 per group). C. Typical images of desmin staining in glomeruli from Asc−/− and Asc+/+ mice with or without HFD. D. Asc−/− improved podocyte ul-
trastructure in HFD treated mice as shown by TEM examinations. The arrow denotes the area of foot process effacement in Asc+/+ mice on the HFD. Images are representative of 5 TEM
images per kidney from 2 mice per group. Original magniﬁcation: ×8000. *Signiﬁcant difference (P b 0.05) compared to the values from ND fed mice, #Signiﬁcant difference (P b 0.05)
compared to the values from Asc+/+ mice receiving the HFD.
841K.M. Boini et al. / Biochimica et Biophysica Acta 1843 (2014) 836–845shRNAmice: 42.4 ± 2.2 vs. 27.3 ± 0.9 g of control at week 10), indicat-
ing that local silencing of Asc gene prevented the obesity-induced
inﬂammasome activation in glomeruli.
Moreover, we determined whether Asc gene silencing locally in the
kidney may attenuate the Nalp3 inﬂammasome formation and protects
against the glomerular injury in obese mice. As illustrated in Fig. 7, the
HFD increased the colocalization of Nalp3 with Asc and Nalp3 with
caspase-1 in glomeruli of mice. However, Asc shRNA transfection signif-
icantly attenuated such HFD-induced colocalization of Nalp3 with Asc
and Nalp3 with caspase-1 (Fig. 7A and B). Consistent with decreased
aggregation of inﬂammasome components in the glomeruli, HFD-
induced caspase-1 activity was also markedly attenuated in Asc
shRNA transfected mice (Fig. 7C). Next, we determined whether Asc
gene silencing locally in the kidney may also protect obesity-induced
podocyte injury and consequent glomerular disease. The urinary pro-
tein excretionwas similar in both scrambled and Asc shRNA transfected
mice fed on the ND. HFD treatment signiﬁcantly increased the urinary
total protein excretion when compared to the ND-fed mice. However,
Asc shRNA transfection signiﬁcantly attenuated HFD-induced increases
in urinary total protein excretion (Fig. 8A). Furthermore, we found that
podocytemarker podocinwasmarkedly reduced in glomeruli of scram-
bled shRNA transfected mice on the HFD compared to those on the ND.
However, this reduced podocin expression or production did not occur
in Asc shRNA transfectedmouse kidney even on theHFD (Fig. 8B and C).
In addition, under TEM the intact structure of podocyte foot processes
shown in glomeruli of mice was observed in ND-fed mice, while it
was destroyed in HFD-fed mice, as shown by evident foot process ef-
facement in scramble shRNA transfected mice on the HFD. In contrast,podocytes of HFD fed Asc shRNA transfectedmice had relatively normal
ultrastructures (Fig. 8D).
Furthermore, we used DBA/2J, another strain of wild type mice to
determine whether Asc gene silencing locally in the kidney also atten-
uates the Nalp3 inﬂammasome formation and protects against the
glomerular injury in obese mice. As illustrated in Supplemental
Fig. 1, the HFD increased the colocalization of Nalp3 with Asc and
Nalp3with caspase-1 in glomeruli of mice. However, Asc shRNA trans-
fection signiﬁcantly attenuated such HFD-induced colocalization of
Nalp3 with Asc and Nalp3 with caspase-1 (Supplemental Fig. 1A and
B). Consistent with decreased aggregation of inﬂammasome compo-
nents in the glomeruli, HFD-induced IL-1β production was also mark-
edly attenuated in Asc shRNA transfected mice (Supplemental
Fig. 1C). The urinary total protein excretion and glomerular damage
index were similar in both scrambled and Asc shRNA transfected
mice fed on the ND. HFD treatment signiﬁcantly increased the urinary
total protein excretion when compared to the ND-fed mice. However,
Asc shRNA transfection signiﬁcantly attenuated HFD-induced in-
creases in urinary total protein excretion and glomerular damage
index (Supplemental Fig. 2A and B). In addition, we found that
podocyte marker podocin was markedly reduced in glomeruli of
scrambled shRNA transfected mice on the HFD compared to those on
the ND. However, this reduced podocin expression or production did
not occur in Asc shRNA transfected mouse kidney even on the HFD
(Supplemental Fig. 2C). In contrast, desmin had more profound abun-
dance in glomeruli of HFD fed mice compared with that in ND-fed
mice. Asc shRNA transfection abrogated the HFD-induced increase in
desmin expression (Supplemental Fig. 2D).
Fig. 6. Renal Asc gene silencing efﬁciency in C57BL/6J mice with or without the high fat diet. A: Daily imaging conﬁrmation of gene transfection in the kidney by an in vivomolecular im-
aging system. B: Localization of transfected gene expression in the hemidissected kidney on day 12 after gene delivery. C: Values are arithmeticmeans± SD (n= 4–8 each group) of Asc
mRNA expression in ND or high fat diet-fed C57BL/6J mice with or without Asc shRNA transfection. *Signiﬁcant difference (P b 0.05) compared to the values from control mice fed on the
normal diet, #signiﬁcant difference (P b 0.05) compared to the values from mice on the high fat diet.
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The major goal of the present study is to determine whether
inﬂammasomes are activated in glomerular podocytes and thereby
lead to podocyte dysfunction and subsequent glomerular injury during
obesity. We demonstrated that HFD-induced increases in NALP3
inﬂammasome formation and activation in glomeruli, which result in
glomerular inﬂammation and consequent glomerular injury. Further-
more, local inhibition of Asc gene completely abolished HFD-induced
NALP3 inﬂammasome formation and activation, podocyte dysfunction
and glomerular injury. Our results for the ﬁrst time suggest that
NALP3 inﬂammasome formation and activation are an important early
mechanism responsible for glomerular inﬂammation and injury in
obese mice.
We ﬁrst characterized the Asc expression in renal tissue of Asc−/−
and Asc+/+ mice. We found that Asc expression was abolished in the
kidneys of Asc−/− mice. These results suggest that the Asc gene is
expressed in renal tissue and gene deletion in Asc−/−mice is successful.
This suggests that the Asc−/− mice may be used for studies on the in-
ﬂammatory mechanisms of obesity and obesity-associated organ dam-
age. In this regard, it has been reported that inﬂammasomes associated
with ASC, in particular, NALP3 inﬂammasome sense obesity-associatedTable 3
Asc mRNA expression in ND fed C57BL/6J WT mice with or without Asc shRNA transfec-
tion.
Parameters Ctrl Asc shRNA
Liver 1.0 ± 0.2 0.9 ± 0.2
Heart 1.0 ± 0.3 1.1 ± 0.2
Adipose tissue 1.0 ± 0.3 1.0 ± 0.1
Quantitative real time PCR analysis was performed and the values were normalized
against β-actin. The data was expressed as mean ± SEM. N = 3–4 in each group.
ND: Normal diet, Ctrl: Control (scramble shRNA).danger signals and contribute to obesity-induced inﬂammation and in-
sulin resistance [21,41]. Knockout of Nalp3 inﬂammasome signiﬁcantly
protects a mice model of HFD-induced obesity, insulin resistance, glu-
cose intolerance and inﬂammation [21,41,51]. Moreover, the expres-
sion of NALP3 subunits in adipose tissue correlates directly with body
weight in mouse models and obese individuals. Indeed, our results
also showed that mice lacking Asc gene signiﬁcantly attenuated the
HFD-induced obesity compared to Asc+/+ mice, indicating the role of
NALP3 inﬂammasomes in obesity.
Recent studies demonstrated the role of NALP3 inﬂammasomes in
chronic kidney diseases including hyperhomocysteinemia-induced glo-
merular injury, acute ischemia reperfusion-induced injury, unilateral
ureteral obstruction and renal biopsies from patients with non-
diabetic kidney diseases [25,26,37–40]. In the present study, we hy-
pothesized that obesity activates the NALP3 inﬂammasome formation
and activation in podocytes and thereby induce local sterile inﬂamma-
tion and glomerular injury. We demonstrated that HFD enhanced the
inﬂammasome formation and increased production of IL-1β resulting
in activation of inﬂammatory response in podocytes of obese Asc+/+
mice, but not in Asc−/− mice. These results suggest that obesity-
induced NALP3 inﬂammasome formation and activation occur in glo-
meruli ofmice. Although this type of inﬂammasomewasﬁrst character-
ized in immune cells, recent studies have demonstrated that it can be
detected in various non-immune cells including intrinsic glomerular
cells [37,39,52,53] and other residential cells in the brain, heart and
vessels [54,55]. To our knowledge, these results represent the ﬁrst
experimental evidence demonstrating that obesity activates NALP3
inﬂammasomes in glomeruli of mice, which is an important pathogenic
mechanism responsible for glomerular injury during obesity.
Using podocin as a podocyte marker, our confocal microscopic ob-
servations demonstrated that HFD-induced inﬂammasome formation
in glomeruli was mostly located in podocytes, as demonstrated by the
colocalization of Nalp3 with podocin. This colocalization was substan-
tially blocked in mice lacking Asc gene. Another interesting ﬁnding of
Fig. 7.Effects of renal Asc silencing on inﬂammasome formation andactivation inC57BL/6J
mice fed with ND or high fat diet. A. Overlaid images (yellow spots) show the
colocalization of Nalp3 (green) with Asc (red) and Nalp3 (green) with caspase-1 (red)
in mouse glomeruli. B. Values are arithmetic means ± SD (n = 6–8 each group) of
caspase-1 activity in glomeruli of ND or HFD fed C57BL/6J WT mice with or without Asc
shRNA transfection. *Signiﬁcant difference (P b 0.05) compared to the values from control
mice on thenormal diet, #Signiﬁcant difference (P b 0.05) compared to versus values from
mice fed the HFD.
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injury in HFD-fedmice, as shown by decrease in podocinmRNA expres-
sion, increase in desmin expression, and foot process effacement. This
HFD-induced podocyte injury was attenuated in mice lacking Asc
gene. These results imply that podocytes are not only a glomerular cell
type with intracellular inﬂammatory machinery featured by the forma-
tion and activation of inﬂammasomes, but also a cell type as a target of
inﬂammatory factors derived from activated NALP3 inﬂammasomes.
The present study did not aim to elucidate the exact mechanism medi-
ating the effect of NALP3 inﬂammasome activation to directly induce
podocyte injury. However, itmay be due to the production of inﬂamma-
tory factors such as IL-1β from activation of NALP3 inﬂammasomes,
which may act in an autocrine or paracrine fashion to change podocyte
function. Indeed, there were reports that various inﬂammatory factors
including IL-1β can induce podocyte injury by reduction of nephrin pro-
duction [52,56]. In addition, the non-inﬂammatory effects of NALP3
inﬂammasome activation such as pyroptosis, cytoskeleton changes
and alteration of cell metabolism have also been reported to mediate
the detrimental action of inﬂammasome activation [57–59].
Furthermore, we demonstrated that inhibition of inﬂammasome
activation has a protective action on the glomerular injury associated
with obesity. In accordance with decreased inﬂammasome formationin Asc−/−mice on the HFD, urinary albumin excretion and glomerular
injury and sclerosis were also signiﬁcantly blocked compared with
Asc+/+ mice on the HFD suggesting that that inﬂammasome formation
and activation are an important early mechanism responsible for
glomerular inﬂammation and injury in obesemice. In particular, activa-
tion of podocyte or glomerular inﬂammasomes is critical for the devel-
opment of glomerular injury associated with obesity. Therefore, the
podocyte inﬂammasome associated with ASC as an intracellular inﬂam-
matory machinery or responder to endogenous danger factors could be
a target of therapeutic strategy for obesity-induced glomerular injury or
sclerosis.
To further address the role of key inﬂammasome adaptor protein
Asc gene inmediatingHFD-induced inﬂammasome formation and glo-
merular injury, a local gene silencing strategy was used in the present
study, where an ultrasound microbubble-mediated plasmid delivery
was employed to introduce Asc shRNA into the kidney. It was demon-
strated that this method was highly efﬁcient in delivering plasmids
into renal cells in vivo. By an in vivo molecular imaging system to
daily monitor the efﬁciency of Asc gene transfection in the kidney in
living animals, we showed that the transgene or shRNA expression
vector (with luciferase gene as an indicator) could be detected even
4 days after gene transfection and lasted for 4 weeks observed. This
in vivo transgene monitoring importantly guided our functional stud-
ies to deﬁne the role of Asc gene in mediating inﬂammasome activa-
tion and glomerular damage associated with obesity. In such local
Asc gene silenced kidney, we found that mRNA expression of Asc,
colocalization of Nalp3 with Asc or caspase-1 in mouse glomeruli,
caspase 1 activity and cleaved IL-1β production was signiﬁcantly
decreased. It was also demonstrated that silencing the Asc gene in
the kidney ameliorates proteinuria and podocyte injury. These results
from mice with local renal Asc gene silencing further support
the conclusion above drawn from studies using Asc−/− mice that
Asc inhibition or gene silencing abolishes HFD-induced action of
inﬂammasome and thereby protect the kidney from obesity-
associated glomerular injury. This protective action was observed
not only in global deletion of Asc gene but also in locally silencing
of this gene in glomeruli, further indicating that glomerular
inﬂammasome may be a therapeutic target for prevention or treat-
ment of obesity-induced glomerular sclerosis. This local gene silenc-
ing will exclude the possible effect of extra-renal gene deletion or
silencing. However, the results from the present study remain to be
elucidated in podocyte speciﬁc ASC inﬂammasome knockout mice.
In conclusion, the present study demonstrated that inhibition of
inﬂammasome activation by global Asc gene deletion or local Asc
gene silencing attenuated the obesity-induced glomerular inﬂam-
mation and injury. The amelioration of glomerular injury by Asc
deﬁciency during obesity implicates the pivotal role of NALP3
inﬂammasomes in obesity-induced glomerulosclerosis. Targeting
ASC-associated inﬂammasomes may be a novel therapeutic strategy
for treatment and management of obesity and associated glomerular
injury.
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D. Asc shRNA-improved podocyte ultrastructure in HFD treated mice as shown by TEM examinations. The arrow denotes the area of foot process effacement in Asc+/+ mice on the HFD.
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